A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
Reports suggest UK soft drinks firm AG Barr could mount a £1bn+ bid for GlaxoSmithKline (GSK) brands Lucozade and Ribena, with support from private equity.
Is there appetite for M&A activity in 2012? Food market watchers reckon the sector could see some heavyweight deals next year despite the on-going credit lending challenges.
Rumour, according to the Romans, is a feathered beast with a myriad eyes and tongues. Last week she went bristling through the Danish business pages, spreading the news that Danisco could be bought by a private equity firm.
Negotiations are underway between private-equity groups over the
sale of French natural ingredients firm Diana-Ingredients,
indicating a positive view of the company's potential in the
marketplace.
Cognis has refused to confirm reports in the German press that it
is in advanced discussions with three potential purchasers, but the
outcome of a strategic review will be made public before the end of
the year.
Cash, cash, cash. Castigated as simple asset-strippers out to make
a quick buck, the entrance of private equity onto the food industry
stage has participants chattering in the wings.
Australian food ingredients firm Burns Philp could be close to
announcing the sale of its North American spice business, Tones
Brothers, for up to $500 million, say Australian media reports.